Sumitomo Mitsui Asset Management Company LTD Sells 3,312 Shares of Thermo Fisher Scientific Inc (TMO)
Sumitomo Mitsui Asset Management Company LTD cut its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 6.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,384 shares of the company’s stock after selling 3,312 shares during the period. Sumitomo Mitsui Asset Management Company LTD’s holdings in Thermo Fisher Scientific were worth $7,695,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Tesco Pension Investment Ltd purchased a new position in shares of Thermo Fisher Scientific during the third quarter worth approximately $137,726,000. FMR LLC increased its position in shares of Thermo Fisher Scientific by 11.3% in the second quarter. FMR LLC now owns 8,216,645 shares of the company’s stock worth $1,214,093,000 after buying an additional 834,858 shares in the last quarter. Carmignac Gestion increased its position in shares of Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock worth $597,918,000 after buying an additional 763,421 shares in the last quarter. Standard Life Investments LTD increased its position in shares of Thermo Fisher Scientific by 618.3% in the third quarter. Standard Life Investments LTD now owns 798,124 shares of the company’s stock worth $126,938,000 after buying an additional 687,018 shares in the last quarter. Finally, Janus Capital Management LLC increased its position in shares of Thermo Fisher Scientific by 50.5% in the second quarter. Janus Capital Management LLC now owns 1,972,203 shares of the company’s stock worth $291,410,000 after buying an additional 661,475 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.01% on Friday, hitting $145.99. The stock had a trading volume of 315,500 shares. The firm’s 50-day moving average is $143.18 and its 200-day moving average is $150.33. The company has a market cap of $57.67 billion, a price-to-earnings ratio of 29.18 and a beta of 1.17. Thermo Fisher Scientific Inc has a one year low of $119.75 and a one year high of $160.68.
Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.06. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. The business had revenue of $4.49 billion for the quarter, compared to analyst estimates of $4.39 billion. During the same quarter last year, the company earned $1.80 EPS. The business’s quarterly revenue was up 8.9% on a year-over-year basis. On average, analysts expect that Thermo Fisher Scientific Inc will post $8.25 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 16th. Stockholders of record on Thursday, December 15th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.41%. The ex-dividend date of this dividend is Tuesday, December 13th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 12.00%.
TMO has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $172.00 price target on the stock in a research note on Thursday, October 13th. Bank of America Corporation set a $180.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Friday, October 7th. Leerink Swann restated a “buy” rating and set a $175.00 price target on shares of Thermo Fisher Scientific in a research note on Sunday, November 20th. J P Morgan Chase & Co initiated coverage on Thermo Fisher Scientific in a research note on Thursday, September 22nd. They set an “overweight” rating and a $180.00 price target on the stock. Finally, Goldman Sachs Group, Inc. (The) restated a “conviction-buy” rating and set a $168.00 price target (down previously from $170.00) on shares of Thermo Fisher Scientific in a research note on Monday, December 12th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $165.22.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.